Summary
What do they do? CBWCHC delivers multilingual primary, dental and mental-health care in Manhattan and Queens. Its clinical teams provide prevention, chronic disease management, therapy and coordinated specialty referrals. Language access, insurance enrollment help and sliding fees support patients facing barriers to affordable care.
Why we’re interested in this organization:
Direct clinical services provide a tangible health mechanism.
Language access and reduced fees address barriers even among insured patients.
Current original financial and patient reporting supports an explicit whole-recipient model.
Our main reservations:
Clinical utility, persistence, patient residence and gift additionality remain unmeasured.
Public/insurance reimbursements and other providers make substitution material; an annual deficit does not establish marginal capacity.
Household medical/travel costs and disposable-pay gains could move combined welfare in either direction.
What do you get for your dollar? $2.4M per DALY in New York City. DALY is our one-year comparison unit. QALY-based health gains and income-welfare equivalents retain their original assumptions; they are not measured clinical DALYs.
Additional effective-care equivalents among annual patients; finite clinical and separate residual/common-alive welfare; finite survival only in a hypothetical stress test.
1. What do they do?
The center offers medical, dental, mental-health, social-work and support services at clinical sites in Manhattan and Queens. Its multilingual staffing can improve access and continuity. Services span prevention and chronic disease management; a visit is not equivalent to an additional healthy year. Services and history Locations
2. Monitoring and information sharing
Request patient-level residence, treatment completion, baseline severity and quality-of-life change, with alternative-provider comparison and durable follow-up. HRSA quality awards and screening performance demonstrate delivery quality, not donor causation. Oregon insurance randomization supplies a cautionary analogy: access can improve mental health while short-term measured physical effects remain undetected. It does not validate our clinic utility coefficient. Original randomized evidence
The IMPACT depression trial supports a clinical pathway in depressed older adults, but its 0–10 quality-of-life scale is not a QALY and its protocol/population is not this recipient. Hepatitis-B antiviral trial evidence demonstrates disease-specific benefit but cannot identify incremental CBWCHC treatment starts or deaths avoided. Survival remains 0 centrally. IMPACT original trial Original antiviral trial
3. Qualitative assessment
Language-concordant care may prevent misunderstandings and help people navigate specialist referrals. The counterfactual includes other community centers, hospitals and insured physician care; an uninsured-only screen would also miss real language barriers. Conversely, treating every existing patient as dependent on a donation greatly overstates marginal impact. Provider context
2025 reported 8% uninsured does not imply that 8% alone receive additional benefit:70%+ best served in non-English languages may face barriers despite insurance. Nor does it justify 20% as measured. The old 0.20/0.02/0.5/0.30 clinical anchor survives only as an explicit conditional judgment; new evidence does not identify a better numerical point. Effective-care and financing substitution are different: the first asks what care adds versus another provider; the second asks what a gift adds versus public reimbursement/reserves/other donors. Both can be 0. Screening quality and awards identify delivery rather than causal outcomes. A claim of cost effectiveness for a marginal unrestricted gift requires a specific capacity plan.
The current insurance page reports a 2026 coverage change. The 2025 uninsured share is not a measured current rate; its consequences for actual donor-funded access and net household costs remain uncertain.
4. What do you get for your dollar?
Latest original recipient annual expense $97,126,149 is retained. The conditional clinical reference is 70,000 patients × 0.20 effective care beyond alternatives × 0.02 mean utility × 0.5 years × 0.30 gift additionality × 0.95 MSA residence = 39.9 MSA QALYs. Signed consumption is included at 0 as an unresolved neutral placeholder, not a finding of no effect; combined reference price is $2.4M per DALY. Utility includes any mental, dental, chronic-care and symptom gains; these pathways are not separately stacked. Residual common-alive wellbeing, mortality and clinical harms are provisionally 0 and tested separately. No benefit continues beyond its finite duration. The full cost and scaled historical outputs are a recipient portfolio allocation, not an observed marginal gift production function. A $1,000 gift corresponds to 0.721 historical patient equivalents before adjustments or 0.043 additional effective-care equivalents under the conditional allocation, not promised extra appointments.
Model, assumptions and sensitivity
Full expense reported in2025 recipient annual report, not sponsor/related-foundation revenue or charity-care discount valuation. Hospital/referral/pharmaceutical costs outside reported expense excluded.
g=.95 judgment: clinical sites in Manhattan and Queens, but residences not supplied. Central allows5% outside the 22-county MSA; g=.8 to1 sensitivity. Site address alone does not establish resident share.
P=N*a*b; commonAlive=P*(1-deathRate); households=N*resourceShare*b*(1-deathRate)*householdsPerPatient; clinical=(commonAlive*u)*discountedYears(t); residual=(commonAlive*residualUtility)*discountedYears(t); harm=(P*harmUtility)*discountedYears(t); survival=P*deathRate*survivalUtility*discountedYears(survivalYears); health=clinical+residual+survival-harm; Ineg=HYE(households,Y,-costs,independentShare1); Ipos=HYE(households,Y-costs,gains,positiveIndependentShare); totalMSA=g*(health+Ineg+Ipos); price10=10*C*f/totalMSA only if positive. Unknown income has no combined price. Each finite stream uses the same delay and annual discount.
- C
- 97126149 USD full-recipient annual expense (observed). Original 2025 annual summary; patient count lower threshold. [annual25]
- f
- 1 forward cost multiplier (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- N
- 70000 annual distinct-patient lower-threshold proxy (observed). Original 2025 annual summary; patient count lower threshold. [annual25]
- a
- 0.2 effective care beyond alternatives, share of patients (judgment). No alternative-provider comparison. Insured language barriers can matter, but 8% uninsured and 70%+ non-English language need do not identify 20% additional effective care.
- u
- 0.02 clinical benefit utility per common-alive additional effective patient (judgment). Finite conditional portfolio utility prior; trials support selected treatment mechanisms and nulls/harms, not this recipient mean. Includes clinical mental-health effects, not stacked with separate depression benefits.
- t
- 0.5 years of clinical/residual/harm exposure (judgment). Half-year finite conditional window; annual patient count gives neither severity nor completed-treatment persistence. Chronic prevention may have delayed gains rather than immediate utility.
- b
- 0.3 gift-financing marginal capacity share (judgment). No measured unrestricted-gift elasticity. Public reimbursement, reserves and alternative donors continue; deficit and gift appeal do not establish 30% marginal capacity.
- g
- 0.95 NYC-MSA resident benefit share (judgment). Clinic sites are local, but beneficiary residence is not reported at 22-county MSA granularity.
- delay
- 0 years before benefit starts (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- discount
- 0 annual discount rate (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- residualUtility
- 0 independent common-alive wellbeing utility (judgment). No independent nonclinical wellbeing effect identified after clinical utility and financial overlap; zero placeholder with separate sensitivity.
- harmUtility
- 0 adverse clinical utility per additional effective patient (judgment). No recipient portfolio harm rate; zero placeholder does not establish no adverse effects. Utility is modeled as benefit before this separate harm term.
- deathRate
- 0 hypothetical fraction whose death is avoided (judgment). No marginal eligible starts, counterfactual mortality or sustained-care evidence; central zero avoids importing selected disease trial mortality across all patients.
- survivalUtility
- 0.8 healthy-year quality weight of additional survival (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- survivalYears
- 5 finite years of additional survival (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- householdsPerPatient
- 0.5 unique affected households per common-alive patient equivalent (judgment). Household deduplication judgment, not measured. Child/adult patients and multiple family members cannot each receive the same household savings independently.
- Y
- 25000 USD annual household baseline consumption (judgment). Scenario baseline household disposable consumption, not gross wage or reported income; patient poverty distribution does not measure this value.
- incomeYears
- 0.5 finite years of household resource-flow change (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- medicalSavings
- 0 USD annual household cash medical savings (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- netDisposablePayGain
- 0 USD annual common-alive household disposable-pay gain (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- medicalCost
- 0 USD annual incremental household medical burden (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- transportCost
- 0 USD annual incremental household transport burden (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- lostDisposablePay
- 0 USD annual household lost disposable-pay burden (judgment). Explicit scenario assumption; not observed recipient-specific causal evidence.
- positiveIndependentShare
- 0.5 independent share of positive log resource benefit (judgment). Half of positive log material benefit retained to limit health/wellbeing overlap; full negative burdens retained.
- incomeKnown
- true scenario treats household financial inputs as evaluable; does not assert measured evidence (judgment). Central zero is an unresolved neutral reference. Unknown-financial explicitly leaves combined result null.
- resourceShare
- 0.2 share of annual patients with incremental household resource effect (judgment). No measured affected-household distribution. Independent of clinical effective-care share so insurance/fee relief need not imply an additional clinical outcome.
Conditional reference; financial balance unresolved at neutral placeholder: Cost: $97.1M; New York City health QALYs: 39.90; all-population health QALYs: 42.00. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
More effective care and persistence: Cost: $97.1M; New York City health QALYs: 672.00; all-population health QALYs: 672.00. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.4,"u":0.04,"t":1,"b":0.6,"g":1,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Mostly substitute care: Cost: $121.4M; New York City health QALYs: 0.35; all-population health QALYs: 0.44. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1.25,"N":70000,"a":0.05,"u":0.005,"t":0.25,"b":0.1,"g":0.8,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
All gifts substitute funding: Cost: $97.1M; New York City health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
No incremental clinical utility: Cost: $97.1M; New York City health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
One quarter clinical utility: Cost: $97.1M; New York City health QALYs: 9.97; all-population health QALYs: 10.50. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.005,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Quarter year gain: Cost: $97.1M; New York City health QALYs: 19.95; all-population health QALYs: 21.00. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.25,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Ten percent marginal financing: Cost: $97.1M; New York City health QALYs: 13.30; all-population health QALYs: 14.00. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.1,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Twenty percent outside MSA: Cost: $97.1M; New York City health QALYs: 33.60; all-population health QALYs: 42.00. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.8,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
One year delay; three percent discount: Cost: $97.1M; New York City health QALYs: 38.74; all-population health QALYs: 40.78. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":1,"discount":0.03,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Original annual-summary mean; not audited three-year mean: Cost: $93.4M; New York City health QALYs: 39.90; all-population health QALYs: 42.00. Income-equivalent healthy years: 0.00. {"C":93413271.66666667,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Hypothetical net saving and common-alive disposable pay: Cost: $97.1M; New York City health QALYs: 39.90; all-population health QALYs: 42.00. Income-equivalent healthy years: 1.98. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":300,"netDisposablePayGain":100,"medicalCost":50,"transportCost":50,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Added treatment/travel/lost disposable pay: Cost: $97.1M; New York City health QALYs: 39.90; all-population health QALYs: 42.00. Income-equivalent healthy years: -10.08. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":200,"transportCost":100,"lostDisposablePay":200,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Same costs with lower baseline consumption and no household deduplication: Cost: $97.1M; New York City health QALYs: 39.90; all-population health QALYs: 42.00. Income-equivalent healthy years: -40.72. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":1,"Y":12500,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":200,"transportCost":100,"lostDisposablePay":200,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Clinical harm exactly offsets clinical gain: Cost: $97.1M; New York City health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0.02,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Clinical harm exceeds gain plus household burdens: Cost: $97.1M; New York City health QALYs: -19.95; all-population health QALYs: -21.00. Income-equivalent healthy years: -10.08. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0.03,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":200,"transportCost":100,"lostDisposablePay":200,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Hypothetical separate common-alive wellbeing: Cost: $97.1M; New York City health QALYs: 49.88; all-population health QALYs: 52.50. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0.005,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Hypothetical 0.01% deaths avoided among additional care; finite five years: Cost: $97.1M; New York City health QALYs: 41.40; all-population health QALYs: 43.58. Income-equivalent healthy years: 0.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0.03,"residualUtility":0,"harmUtility":0,"deathRate":0.0001,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Household balance cannot be estimated: Cost: $97.1M; New York City health QALYs: 39.90; all-population health QALYs: 42.00. {"C":97126149,"f":1,"N":70000,"a":0.2,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":0,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":false,"resourceShare":0.2}
Hypothetical resource relief without additional clinical benefit: Cost: $97.1M; New York City health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 2.97. {"C":97126149,"f":1,"N":70000,"a":0,"u":0.02,"t":0.5,"b":0.3,"g":0.95,"delay":0,"discount":0,"residualUtility":0,"harmUtility":0,"deathRate":0,"survivalUtility":0.8,"survivalYears":5,"householdsPerPatient":0.5,"Y":25000,"incomeYears":0.5,"medicalSavings":300,"netDisposablePayGain":0,"medicalCost":0,"transportCost":0,"lostDisposablePay":0,"positiveIndependentShare":0.5,"incomeKnown":true,"resourceShare":0.2}
Counterfactual: Existing public/private insurance, federal grants, alternative community providers and other donors continue. a=.2 isolates care beyond alternatives; b=.3 separately accounts for donation-financing substitution.
Attribution: Whole-recipient annual resource allocation. Additional clinical utility beyond alternatives and marginal gift financing are separate conditional factors. No measured donor slots.
Very weak conditional reference, not measured causal impact. All benefit/additionality/income/geographic coefficients are judgments; unknown consumption remains visibly unresolved, not proven zero. Scenario endpoints are inspectable judgments rather than statistical intervals.
Sensitivity
- Zero capacity or zero clinical gain can remove all central benefit.
- Full household burden can reduce net welfare; positive resources are overlap-limited.
- Clinical harm.02for half a year offsets the clinical reference; larger harm yields net harm.
- Unknown-financial case has no combined price; the central financial0is a placeholder.
Unresolved inputs
- Audited2025 statements including consolidation, funding restrictions and liquidity.
- Marginal staffing/program plan and how much extra capacity unrestricted gifts buy.
- MSA patient residence shares and alternative-provider access.
- Recipient-specific utility, duration and adverse-effects evidence for the clinical portfolio.
- Signed household balance after insurance, taxes, benefits, transport, extra medications and lost pay; overlap with health utility.
- Controlled diagnosis-specific clinical utility, completion and finite duration; adverse effects and survival baseline.
Health and income breakdown
For the modeled $97.1M: 39.90 health QALYs + 0.00 income-equivalent healthy years in New York City: $2.4M per DALY. Income equivalents are welfare comparisons, not observed QALYs or DALYs.
5. Funding and previous grants
The 2025 annual report's financial page reports $82,219,650 program expenses plus $14,906,499 general/administrative expense, totaling $97,126,149. Revenue is $89,787,848, of which $61,388,351 is patient services; the reported decrease in net assets is $7,338,301. Audit status, precise period dates and consolidation detail are not provided on that page, so no audited three-year mean is claimed. Original report, printed page 11
Giving is directed to the operating health center; the official page identifies programs exceeding conventional reimbursement. A budget deficit does not prove a 30% gift elasticity; unrestricted gifts may replace funds or maintain existing care. Our model follows the recipient-wide mix without claiming a restricted offer. Official donation page
Deep review retains the latest original full expense. Original 2024/2023 annual summaries give $96,968,903/$86,144,763; their three-year mean $93,413,271.67 is tested, not called an audited mean. The 2023 audit includes Healthview and eliminates internal rent: consolidated functional expense $86,144,763 versus operating-center standalone $86,810,288.2024/2025 audit downloads returned 403; current consolidation/audit detail is still missing. Original 2023 audit
Annual expenses
Annual size figure used in comparisons
$97.1M — 2025 reported expense summary. 2025 annual report; exact fiscal period and audit scope unverified.
The annual-report financial summary shows $82,219,650 program services plus $14,906,499 administration. The period length, audit status and consolidation boundary are unverified; do not treat this as a comparable three-year mean.
2025 annual report, printed pages 3 and 11 visually verified · Reviewed 2026-10-18.
Organization-level spending, including programs, administration and fundraising. The research list averages three comparable, consecutive full fiscal years when available.
- FY 2025: $97.1M; Charles B. Wang Community Health Center, period length unverified, Original2025 annual-report financial summary; audit and exact dates not stated. Source
- FY 2024: $97.0M; Annual summary, consolidation unverified, period length unverified, Original annual-report financial summary, not verified audit. Source
- FY 2023: $86.1M; CBWCHC and controlled Healthview consolidated, 12-month period, Original consolidated audit functional expense includes depreciation and eliminates internal rent. Source
6. Sources
- 2025 annual report, printed pages 3 and 11 visually verified. Charles B. Wang Community Health Center. Published: not stated; retrieved: 2026-09-29.
- About the center and current patient services. Charles B. Wang Community Health Center. Published: not stated; retrieved: 2026-09-29.
- Clinical site locations. Charles B. Wang Community Health Center. Published: not stated; retrieved: 2026-09-29.
- Official gift allocation and recipient. Charles B. Wang Community Health Center. Published: not stated; retrieved: 2026-09-29.
- Oregon Experiment—Effects of Medicaid on Clinical Outcomes. New England Journal of Medicine. Published: 2013-05-02; retrieved: 2026-09-29.
- Original 2024 annual report. Charles B. Wang Community Health Center. Published: not stated; retrieved: 2026-10-05.
- Original 2023 consolidated audit. Original primary source. Published: not stated; retrieved: 2026-10-05.
- IMPACT randomized depression trial. Original primary source. Published: not stated; retrieved: 2026-10-05.
- Original antiviral progression trial. Original primary source. Published: not stated; retrieved: 2026-10-05.
- Current insurance and sliding-fee services. Original primary source. Published: not stated; retrieved: 2026-10-05.